Alternatives to Evista If You Can't Fill Your Prescription

If you're unable to fill your Evista (raloxifene) prescription — whether because your pharmacy is out of stock, your insurance denied coverage, or costs are a barrier — you have options. This post covers the most common alternatives to Evista for its two main uses: treating and preventing osteoporosis and reducing the risk of invasive breast cancer in postmenopausal women. Always talk to your prescriber before switching medications.

First: Evista Is a Unique Medication — Here's Why Alternatives Are Complicated

Evista's active ingredient, raloxifene, is one of only a few drugs that simultaneously addresses both osteoporosis and breast cancer risk. It works by mimicking estrogen in bone tissue (reducing bone loss) while blocking estrogen in breast tissue (reducing cancer risk). This dual action is why there's no single "perfect" substitute — different alternatives address one benefit but not necessarily both.

Alternative 1: Alendronate (Fosamax) — Best for Osteoporosis

Alendronate (brand name Fosamax) is a bisphosphonate and the most commonly prescribed first-line treatment for osteoporosis. It works by slowing bone breakdown, similar to raloxifene, but through a different mechanism. Bisphosphonates like alendronate have a stronger track record for reducing hip fracture risk.

Pros: Well-studied, reduces risk of both vertebral and hip fractures, widely available, inexpensive as a generic (often under $10/month).

Cons: Must be taken on an empty stomach with a full glass of water, then remain upright for 30–60 minutes. Can cause GI side effects. Does NOT reduce breast cancer risk.

Dosing: 10 mg daily or 70 mg once weekly tablet.

Alternative 2: Risedronate (Actonel/Atelvia) — Another Bisphosphonate

Risedronate is another bisphosphonate that works similarly to alendronate but may be better tolerated by some patients. It's available as a weekly pill (Actonel) or a delayed-release weekly tablet (Atelvia, taken after breakfast).

Pros: Reduces both vertebral and hip fracture risk. Atelvia's delayed-release formulation may be easier on the stomach.

Cons: Still requires specific dosing instructions. Does NOT reduce breast cancer risk.

Alternative 3: Denosumab (Prolia) — Injection for Osteoporosis

Denosumab (Prolia) is a biologic monoclonal antibody given as a subcutaneous injection every 6 months. It works by blocking RANK ligand, a protein that activates bone-dissolving osteoclast cells. Prolia is very effective at reducing fracture risk, including hip fractures.

Pros: Only twice-yearly dosing. Good option if bisphosphonates cause GI side effects. Potent bone-building effects.

Cons: Requires injection from a healthcare provider. Stopping denosumab without transitioning to another medication can cause rapid bone loss. Does NOT reduce breast cancer risk. Can be expensive.

Alternative 4: Tamoxifen — For Breast Cancer Risk Reduction Only

Tamoxifen is another SERM approved for reducing the risk of invasive breast cancer in high-risk women. Unlike raloxifene, tamoxifen works in both premenopausal and postmenopausal women. However, it carries a higher risk of uterine cancer and blood clots compared to raloxifene, and it does NOT treat osteoporosis.

Pros: Can be used in premenopausal women. Effective at reducing invasive breast cancer risk.

Cons: Higher risk of uterine cancer and blood clots than raloxifene. Does not treat osteoporosis. Causes hot flashes and other menopausal symptoms.

Alternative 5: Zoledronic Acid (Reclast) — Annual IV Infusion

Zoledronic acid (Reclast) is a potent bisphosphonate given as a once-yearly intravenous infusion. It's convenient in that you only need it once a year, but it must be administered at a clinic or infusion center. It strongly reduces hip and vertebral fracture risk.

Pros: Only one treatment per year. Very effective for hip and vertebral fracture prevention. Avoids GI side effects of oral bisphosphonates.

Cons: Requires IV administration. Can cause flu-like symptoms for a few days after first dose. Does NOT reduce breast cancer risk.

How to Talk to Your Doctor About Switching

Before changing your osteoporosis medication, your doctor will consider your fracture risk, bone density (DEXA scan results), personal history, and tolerance for side effects. Bring up:

Why you need an alternative (availability issue, cost, side effects)

Whether the breast cancer risk reduction benefit is also a priority for you

Your GI history (important for choosing bisphosphonate formulation)

History of blood clots, as this affects SERM safety

Don't Switch Without Trying to Find Evista First

If your pharmacy is simply out of stock, try medfinder to locate a nearby pharmacy that can fill your prescription before considering alternatives. Switching medications when the supply issue is temporary can cause unnecessary disruption to your treatment plan. Read our guide on how to find Evista in stock near you for more options.